We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
An independent tribunal responsible for handling appeals against decisions made by the Secretary of State for Health and Social Care from pharmaceutical companies.
An agreement between DHSC and the ABPI on getting the best value and most effective medicines into use more quickly.
Controlled drugs and precursor chemicals licensing fees information for individuals and companies.
How to use an economic evaluation to evaluate your digital health product.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Seeks views on proposals to change to how prices of branded NHS medicines are determined and re-align savings alongside PPRS.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
This consultation seeks views on proposals to update the statutory scheme to control the cost of branded health service medicines.
Work out the VAT liability of goods and services supplied by health and care institutions and providers of non residential care to children.
This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
This brief considers the main regulatory frameworks and the scope for achieving better access to medicines
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.